Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

332.15
Delayed Data
As of Feb 16
 -1.03 / -0.31%
Today’s Change
313.53
Today|||52-Week Range
543.55
-11.65%
Year-to-Date
Top Research Reports for Novo Nordisk, TJX Companies & Cigna
Feb 16 / Zacks.com - Paid Partner Content
Regeneron (REGN) Tops Q4 Earnings & Sales
Feb 08 / Zacks.com - Paid Partner Content
Sustainable Growth Advisers, LP Buys Yum Brands Inc, Walt Disney Co, Regeneron Pharma...
Feb 13 / GuruFocus News - Paid Partner Content
Sanofi (SNY) Q4 Earnings Lag on Weak Diabetes/Vaccines Sales
Feb 07 / Zacks.com - Paid Partner Content
Wall Street Falls Tuesday Morning
Feb 13 / GuruFocus News - Paid Partner Content
REGN vs. ALXN: Which Stock is Poised for Better Q4 Earnings?
Feb 07 / Zacks.com - Paid Partner Content
Handling Your Finances at Any Age: Cramer's 'Mad Money' Recap (Monday 2/12/18)
Feb 12 / TheStreet.com - Paid Partner Content
Will Regeneron (REGN) Disappoint Investors in Q4 Earnings?
Feb 05 / Zacks.com - Paid Partner Content
Regeneron (REGN) Q4 Earnings & Revenues Top, Eylea Sales Grow
Feb 08 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close333.18
Today’s open334.00
Day’s range328.95 - 341.08
Volume1,175,433
Average volume (3 months)929,300
Market cap$35.8B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+20.82%
P/E ratio32.1
Price/Sales7.42
Price/Book5.82

Competitors

 Today’s
change
Today’s
% change
SHPGShire-1.24-0.92%
VRTXVertex Pharmaceutica...-0.22-0.14%
BAXBaxter International...-0.11-0.17%
ALXNAlexion Pharmaceutic...-2.24-1.83%
Data as of 4:15pm ET, 02/16/2018

Financials

Last reporting dateFebruary 8, 2018
EPS forecast (this quarter)$4.47
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts